Viewing Company
Company Name:
Mainz Biomed N.V.
CIK:
1874252
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2022-05-03
Last Filing Date:
2025-03-31
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2021-01-01 | 2021-12-31 | CY2021Q4I | 2022-05-03 | 0001213900-22-023291 | $ 8,727,542 | View |
| 2022-01-01 | 2022-06-30 | CY2022Q2I | 2022-09-07 | 0001213900-22-054323 | $ 382,500 | View |
| 2022-01-01 | 2022-12-31 | CY2020 | 2023-04-07 | 0001213900-23-028320 | $ 17,328,942 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1 | 2023-05-16 | 0001213900-23-040123 | $ 300,000 | View |
| 2023-04-01 | 2023-06-30 | CY2023Q2 | 2023-08-15 | 0001213900-23-067428 | $ 432,780 | View |
| 2023-01-01 | 2023-09-30 | CY2023Q3I | 2023-11-16 | 0001213900-23-087705 | $ 1,052,693 | View |
| 2023-01-01 | 2023-12-31 | CY2022Q4I | 2024-04-09 | 0001213900-24-031299 | $ 121,735 | View |
| 2024-01-01 | 2024-06-30 | CY2024Q2I | 2024-10-18 | 0001213900-24-088934 | $ 0 | View |
| 2024-01-01 | 2024-12-31 | CY2024Q4I | 2025-03-31 | 0001213900-25-026430 | $ 1,419,730 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| ifrs-full | 2610589 | None | View |
| us-gaap | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Amortization | The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. | View |
| us-gaap | Net Asset Value Per Share | Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure. | View |
| us-gaap | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | View |
| us-gaap | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. | View |
| us-gaap | Stock Dividends, Shares | Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits. | View |